Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1
Abstract
Objective:
Methods:
Results:
Conclusions:
ClinicalTrials.gov identifier:
Classification of evidence:
Get full access to this article
View all available purchase options and get full access to this article.
Supplementary Material
REFERENCES
Information & Authors
Information
Published In
Copyright
Publication History
Disclosure
Study Funding
Authors
Author Contributions
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
- Neurofibromatosis type 1, Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease, (231-249), (2025).https://doi.org/10.1016/B978-0-443-19176-3.00017-0
- Drosophila Contributions towards Understanding Neurofibromatosis 1, Cells, 13, 8, (721), (2024).https://doi.org/10.3390/cells13080721
- Gender-Specific Fine Motor Skill Learning Is Impaired by Myelin-Targeted Neurofibromatosis Type 1 Gene Mutation, Cancers, 16, 3, (477), (2024).https://doi.org/10.3390/cancers16030477
- Neurocognitive therapies for monogenic conditions: Time for a new approach?, Developmental Medicine & Child Neurology, (2024).https://doi.org/10.1111/dmcn.16129
- Lamotrigine for cognitive deficits associated with neurofibromatosis type 1: A phase II randomized placebo‐controlled trial , Developmental Medicine & Child Neurology, (2024).https://doi.org/10.1111/dmcn.16094
- The lipid droplet in cancer: From being a tumor‐supporting hallmark to clinical therapy, Acta Physiologica, 240, 3, (2024).https://doi.org/10.1111/apha.14087
- Modeling neurodegenerative and neurodevelopmental disorders in the Drosophila mushroom body , Learning & Memory, 31, 5, (a053816), (2024).https://doi.org/10.1101/lm.053816.123
- An evaluation of computerized attention and executive function measures for use with school age children with neurofibromatosis type 1, Child Neuropsychology, 30, 6, (938-953), (2024).https://doi.org/10.1080/09297049.2024.2302634
- Drug repurposing for cancer therapy, Signal Transduction and Targeted Therapy, 9, 1, (2024).https://doi.org/10.1038/s41392-024-01808-1
- Systematic Review and Meta-Analysis: Attention-Deficit/Hyperactivity Disorder Symptoms in Children With Neurofibromatosis Type 1, Journal of the American Academy of Child & Adolescent Psychiatry, (2024).https://doi.org/10.1016/j.jaac.2024.09.011
- See more
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.